This cluster of papers focuses on the metastatic behavior, clinicopathological characteristics, molecular profiling, and therapeutic targets of metastatic carcinomas, particularly from lung tumors and breast cancer. It explores the role of GATA3 as a prognostic marker, the use of immunohistochemistry in diagnosis, and the identification of potential therapeutic targets for these aggressive metastatic cancers.